Fresenius Kabi Contract Manufacturing goes to the US

January 15, 2021

Over the past decade, Fresenius Kabi has become a household name for providing contract manufacturing services in the pharmaceutical industry. To be reliable as a global partner, we understand that being close to both our customers and manufacturing sites is vital for establishing long-lasting and successful relationships.


More than ten years ago, Fresenius Kabi decided to have a stronger footprint in North America and focus on the US market and has since acquired three manufacturing sites – in Melrose Park, IL, Grand Island, NY, and Wilson, NC. These sites have the ability to manufacture sterile liquid injectables ranging from price-competitive standard solutions in high quantities to complex products with specific manufacturing requirements, for example for use with disposable equipment with high yield and quality requirements and for either US or global markets.  The containers for filling and finishing range from glass and plastic vials to prefilled syringes and PVC-free proprietary freeflex® bags. In order to satisfy increased market demands but also to remain state of the art with technologies and regulatory requirements, Fresenius Kabi is currently making investments for extensions in all three US sites and has taken the decision to make Fresenius Kabi Contract Manufacturing a central pillar for its future strategy in the US.


To support all our new and existing partners directly in the US to the best level, this year, we have formed a new US team with Courtney Roman located in Melrose Park, IL, Erin Crawford in Grand Island, NY, and Wanda Mason in Wilson, NC. They have all previously been in different positions at Fresenius Kabi and have extensive knowledge of the local manufacturing sites. We would like to wish Courtney, Erin, and Wanda a warm welcome to the Fresenius Kabi Contract Manufacturing US team!




Grand Island


The Grand Island Production Unit is located just over ten miles away from Buffalo, NY, and a few minutes away from the spectacular Niagara Falls. Buffalo is in the Western New York region in the northeast of the US and is the second largest city in New York state. The Grand Island plant has an impressive 50-year manufacturing history with the last 12 of those years being under Fresenius Kabi ownership with significant investments of approximately USD 200 M within the last decade. Read more...




Melrose Park


Do you have a developed parenteral injectable product in glass vials (2–200 mL) and are you looking for a high throughput facility to partner with for Phase 3 and/or for commercialization? If so, then the brand-new Fresenius Kabi Melrose Park Production Unit is for you. We are located in a general industrial area in the outskirts of Chicago, five miles away from O’Hare International Airport. The facility became a licensed pharmaceutical plant in 1984, has more than 12 years history within Fresenius Kabi, and currently produces a wide range (250 finished products) of parenteral injectable medicines for the treatment of critically and chronically ill patients. Read more...






Our Fresenius Kabi US excellence center for prefilled syringes (PFS) is in Wilson, which is located in the eastern part of North Carolina. The Wilson site is a world-class facility with state-of-the-art, fully automated syringe technologies that are focused on the production and distribution of complex and critical drugs in ready-to-administer delivery systems and diluents, both for Fresenius Kabi and contract manufacturing partners. Read more...